PM
50
5
WYNN
30
-2
KMB
31
3
MSFT
43
-5
MLM
27
-7
MTCH
62
7
USB
50
2
ITW
33
-9
FOX
70
6
CL
40
-2
ORLY
39
-6
JWN
50
-5
SYF
69
-5
THC
43
-6
AMGN
42
3
OXY
40
3
HON
64
6
FIS
50
7
AIV
40
-6
CME
37
-5
PM
50
5
WYNN
30
-2
KMB
31
3
MSFT
43
-5
MLM
27
-7
MTCH
62
7
USB
50
2
ITW
33
-9
FOX
70
6
CL
40
-2
ORLY
39
-6
JWN
50
-5
SYF
69
-5
THC
43
-6
AMGN
42
3
OXY
40
3
HON
64
6
FIS
50
7
AIV
40
-6
CME
37
-5
Financhill
Back

Range Cancer Therapeutics ETF Stock Predictions

Hidden Stock Under $5 Holds Tech World Hostage

Click here to see more.
Sell
36

CNCR
Range Cancer Therapeutics ETF

Last Price:
$12.95
Seasonality Move:
-2.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Could This Stock Under $5 Be Your Biggest Opportunity?

Click here to learn more.

Range Cancer Therapeutics ETF Stock Forecast

  • Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically fallen by 5.9% based on the past 9 years of stock performance.
  • Range Cancer Therapeutics ETF has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Range Cancer Therapeutics ETF Stock Undervalued?
    The current Range Cancer Therapeutics ETF [CNCR] share price is $12.60. The Score for CNCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Range Cancer Therapeutics ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically fallen by 5.9% based on the past 9 years of stock performance.

Range Cancer Therapeutics ETF Stock Rating

Sell
36
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF overpriced?

  • Range Cancer Therapeutics ETF has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Range Cancer Therapeutics ETF Stock Price History

Is CNCR stock going to rise?

  • The current trend is relatively stagnant and CNCR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
17.96
52-Week Low:
11.87

Prediction Charts

Market Cap:
0
Price in USD:
12.60
Volume:
2.6K
Beta:
1.12

Technical Analysis

SMA50:
14.00
SMA100:
14.42
SMA200:
14.65
52-Wk Change:
-7.62%

Stock Predictions

  • Is Range Cancer Therapeutics ETF stock public?
    Yes, Range Cancer Therapeutics ETF is a publicly traded company.
  • What is the Range Cancer Therapeutics ETF stock quote today?
    The Range Cancer Therapeutics ETF stock price is 12.60 USD today.
  • How to buy Range Cancer Therapeutics ETF stock online?
    You can buy Range Cancer Therapeutics ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-10 14.14 13.74 14.14 13.81
Dec-11 13.89 13.67 13.89 13.60
Dec-12 13.49 13.01 13.50 13.05
Dec-13 12.94 12.68 12.94 12.62
Dec-16 12.88 12.81 12.92 12.81
Dec-17 12.68 12.66 12.70 12.61
Dec-18 12.62 12.02 12.63 11.95
Dec-20 11.87 12.09 12.21 11.87
Dec-24 12.33 12.35 12.35 12.23
Dec-26 12.33 12.61 12.53 12.24
Dec-27 12.61 12.49 12.61 12.24
Dec-30 12.33 12.17 12.33 12.07
Dec-31 12.27 12.31 12.31 12.06
Jan-2 12.45 12.60 12.83 12.45

Range Cancer Therapeutics ETF Earnings

Data Unavailable

Range Cancer Therapeutics ETF Forecast Revenue Growth

Data Unavailable

* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.